25 results
8-K
EX-10.1
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
and pronouns stated in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter, (c) the words “hereof
8-K
EX-10.2
CRNX
Crinetics Pharmaceuticals Inc
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
in either the masculine, the feminine or neuter gender shall include the masculine, feminine and neuter, (c) the words “hereof,” “herein” and words
8-K
EX-99.1
h99a5op60agl 3r963
29 Jul 21
Stock Purchase Agreement
4:15pm
DEF 14A
yk4nw81azkjv3h
29 Apr 19
Definitive proxy
12:00am
424B4
8bl4c lruq7n
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
z1k3rl43
9 Jul 18
IPO registration (amended)
6:10am
S-1/A
EX-10.8
zw4uvmr9ekd8ees 5oc5
9 Jul 18
IPO registration (amended)
6:10am
S-1
EX-10.9
so2ndkx0 7pq2mo1
22 Jun 18
IPO registration
4:07pm
S-1
EX-10.7
if2sy3k64mo bpl0
22 Jun 18
IPO registration
4:07pm
S-1
u5pjttc9gr90346iiw6m
22 Jun 18
IPO registration
4:07pm
S-1
EX-10.6
bpo4miwo063m5najbj1m
22 Jun 18
IPO registration
4:07pm
DRS/A
EX-10.6
7ua5722vn3 9w0q4s8kc
11 Jun 18
Draft registration statement (amended)
12:00am
DRS/A
rgcgiq
11 Jun 18
Draft registration statement (amended)
12:00am